Compounds > terizidone
Page last updated: 2024-08-24

terizidone and Tuberculosis, Pulmonary

terizidone has been researched along with Tuberculosis, Pulmonary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Court, R; de Vries, N; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Stewart, A; Wiesner, L1
Davis, JG; Farley, J; Lancaster, J; Odendaal, R; Shean, K; Van der Walt, M1

Other Studies

2 other study(ies) available for terizidone and Tuberculosis, Pulmonary

ArticleYear
Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2018, 01-01, Volume: 22, Issue:1

    Topics: Adult; Antitubercular Agents; Area Under Curve; Chromatography, Liquid; Cycloserine; Female; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Oxazolidinones; Prospective Studies; Regression Analysis; South Africa; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2018
Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Adult; Antitubercular Agents; Coinfection; Cycloserine; Drug Resistance, Multiple, Bacterial; Female; Hearing Loss; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Prospective Studies; Psychoses, Substance-Induced; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2013